Supriya Lifesci.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE07RO01027
  • NSEID: SUPRIYA
  • BSEID: 543434
INR
620.25
-4.2 (-0.67%)
BSENSE

Nov 20

BSE+NSE Vol: 1.47 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003587,
    "name": "Supriya Lifesci.",
    "stock_name": "Supriya Lifesci.",
    "full_name": "Supriya Lifescience Ltd",
    "name_url": "stocks-analysis/supriya-lifesci",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "620.25",
    "chg": -4.2,
    "chgp": "-0.67%",
    "dir": -1,
    "prev_price": "624.45",
    "mcapval": "4,934.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543434,
    "symbol": "SUPRIYA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE07RO01027",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "1.47 lacs",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/supriya-lifesci-1003587-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Supriya Lifescience Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/supriya-lifescience-ltd-is-rated-sell-4265269",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SupriyaLifescie_mojoScore_4265269.png",
        "date": "2026-11-17 10:10:27",
        "description": "Supriya Lifescience Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 2 November 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 November 2026, providing investors with the most recent and relevant data to assess the company’s outlook."
      },
      {
        "title": "Supriya Lifescience Ltd Hits Intraday Low Amid Price Pressure on 9 Nov 2026",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/supriya-lifescience-ltd-hits-intraday-low-amid-price-pressure-on-9-nov-2026-4256852",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SupriyaLifescie_priceRelatedfactors_4256852.png",
        "date": "2026-11-09 10:22:00",
        "description": "Supriya Lifescience Ltd experienced a notable decline today, touching an intraday low of Rs 602.45, reflecting a sharp price pressure of -7.51%. The stock underperformed its sector and broader market indices, continuing a downward trend that has persisted over the last three sessions."
      },
      {
        "title": "Supriya Lifescience Drops 17.76% Amid Technical Shifts and Valuation Concerns",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/supriya-lifescience-drops-1776-amid-technical-shifts-and-valuation-concerns-4255066",
        "imagepath": "",
        "date": "2026-11-07 12:01:41",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Nov:</strong> Stock opens at ₹838.30, down 0.93% amid mixed market signals</p>\n                    <p><strong>3 Nov:</strong> Technical momentum shifts to sideways; stock closes at ₹832.35 (-0.71%)</p>\n                    <p><strong>4 Nov:</strong> Strong rebound with 3.41% gain to ₹860.70 on renewed buying interest</p>\n                    <p><strong>5 Nov:</strong> Mildly bullish technical stance; stock rises 1.01% to ₹869.40</p>\n                    <p><strong>6 Nov:</strong> Sharp plunge of 19.96% to ₹695.90; hits lower circuit amid heavy selling</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-labe..."
      },
      {
        "title": "Supriya Lifescience Ltd Locks at Lower Circuit With 20% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/supriya-lifescience-ltd-plunges-to-lower-circuit-amid-heavy-selling-pressure-4254422",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SupriyaLifescie_stocks_hitting_lower_circuit_4254422.png",
        "date": "2026-11-06 14:00:08",
        "description": "At Rs 704.05, Supriya Lifescience Ltd locked at its lower circuit limit of 20% on 6 Nov 2026, with sellers lined up but no buyers willing to absorb the supply. This freeze at the floor price reflects unfilled sell orders and a market unable to find demand at these levels."
      },
      {
        "title": "Supriya Lifescience Ltd Hits Intraday Low Amid Price Pressure on 6 Nov 2026",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/supriya-lifescience-ltd-hits-intraday-low-amid-price-pressure-on-6-nov-2026-4254332",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SupriyaLifescie_priceRelatedfactors_4254332.png",
        "date": "2026-11-06 13:03:22",
        "description": "Supriya Lifescience Ltd experienced a notable decline in intraday trading on 6 Nov 2026, touching a low of Rs 774.1, reflecting a sharp price correction amid broader market gains. The stock underperformed its sector and the benchmark Sensex, signalling immediate selling pressure and subdued market sentiment towards the small-cap pharmaceutical firm."
      },
      {
        "title": "Supriya Lifescience Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/supriya-lifescience-ltd-is-rated-sell-4253880",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SupriyaLifescie_mojoScore_4253880.png",
        "date": "2026-11-06 10:11:34",
        "description": "Supriya Lifescience Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 Nov 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 November 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Supriya Lifescience Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/supriya-lifescience-ltd-sees-technical-momentum-shift-amid-mixed-indicator-signals-4251511",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SupriyaLifescie_technicaldot_4251511.png",
        "date": "2026-11-05 08:06:37",
        "description": "Supriya Lifescience Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite this positive directional change, key technical indicators such as MACD and KST remain mildly bearish on weekly and monthly timeframes, while moving averages on the daily chart suggest emerging strength. This nuanced technical landscape warrants a detailed analysis for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Supriya Lifescience Ltd is Rated Hold by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/supriya-lifescience-ltd-is-rated-hold-by-marketsmojo-4238706",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/SupriyaLifescie_mojoScore_4238706.png",
        "date": "2026-10-26 10:10:26",
        "description": "Supriya Lifescience Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 31 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 October 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Supriya Lifescience Ltd Valuation Shifts Signal Changing Market Sentiment",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/supriya-lifescience-ltd-valuation-shifts-signal-changing-market-sentiment-4232776",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/SupriyaLifescie_valuationdot_4232776.png",
        "date": "2026-10-22 08:01:51",
        "description": "Supriya Lifescience Ltd has witnessed a notable shift in its valuation parameters, moving from a very expensive to an expensive rating. This change reflects evolving market perceptions amid fluctuating price-to-earnings and price-to-book value ratios, prompting investors to reassess the stock’s price attractiveness relative to its historical averages and peer group within the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 75,
    "sid": "1003587",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/supriya-lifescience-1003587"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "13-Nov-2026",
      "details": "Earnings Call Transcript is enclosed herewith.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "07-Nov-2026",
      "details": "Newspaper Advertisement enclosed herewith.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting For Quarter And Half Year Ended Ended September 30 2026.",
      "datetime": "06-Nov-2026",
      "details": "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Board of Directors of the Company at its Meeting held on Friday November 6 2026 inter-alia to considered and approved the following:",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Supriya Lifescience Ltd has declared <strong>50%</strong> dividend, ex-date: 04 Sep 26",
          "dt": "2026-09-04",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

13-Nov-2026 | Source : BSE

Earnings Call Transcript is enclosed herewith.

Announcement under Regulation 30 (LODR)-Newspaper Publication

07-Nov-2026 | Source : BSE

Newspaper Advertisement enclosed herewith.

Board Meeting Outcome for Outcome Of Board Meeting For Quarter And Half Year Ended Ended September 30 2026.

06-Nov-2026 | Source : BSE

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Board of Directors of the Company at its Meeting held on Friday November 6 2026 inter-alia to considered and approved the following:

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Supriya Lifescience Ltd has declared 50% dividend, ex-date: 04 Sep 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available